GlobeNewswire

ConnectWise Announces New Solutions Designed to Reduce Complexity, Improve Efficiency and Drive Revenue

Dela

ORLANDO, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ConnectWise© welcomed more than 3,500 attendees to IT Nation today and Arnie Bellini, Chief Executive Officer, shared details on ConnectWise's vision to help technology solution providers (TSPs) build efficiencies and drive growth across their critical practice areas. As an integrated suite that features over 200 third-party integrations, ConnectWise is well positioned to expand the ecosystem for TSPs and Bellini highlighted some of the recent offerings reinforcing that direction.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/694ab680-f928-4363-8c2f-d70bb8ee2573

Extending the Reach of ConnectWise Unite
Last week, ConnectWise unveiled a pilot program for ConnectWise Unite(TM), a new solution to help TSPs automate and streamline billing, while also providing cloud-based monitoring and management. ConnectWise Unite allows Cisco partners to access and manage all Cisco Spark, Cisco Meraki, Cisco Umbrella and Cisco Stealthwatch solutions from a single management console. TSPs can sign up for a free trial of ConnectWise Unite with Cisco, which runs through Jan. 1, 2018.

ConnectWise Unite is also designed for TSPs that use Amazon Web Services for their cloud-based management and billing of virtual machines and storage. ConnectWise Unite solutions are built on the same foundation as ConnectWise CloudConsole(TM), which provides ConnectWise partners with an all-in-one tool for Microsoft Office 365 and Microsoft Azure cloud services.

"Our focus and passion for more than 35 years has been to find ways for TSPs to increase their efficiency, enhance visibility into their businesses and grow their businesses," said Bellini. "ConnectWise Unite does just that by drastically reducing the complexity and costs of managing multiple cloud solutions, while giving businesses of all sizes the ability to quickly reap the business advantages of recurring revenues."

First Look at What's Coming in 2018 
Coming in 2018, the ConnectWise Developer Kit will be used to make it simple and fast to connect to the ConnectWise platform. It will allow development teams to quickly connect anything in the ecosystem to the ConnectWise platform. The ConnectWise Developer Kit will provide a single pane of glass that unites our ecosystem. Bellini said ConnectWise's ongoing commitment to ensuring TSPs can choose which solutions work best for their businesses is the driving factor behind the idea of the ConnectWise Developer Kit.

"We understand that one-size-fits-all solutions are not practical in an ever-evolving ecosystem as diverse as the one in which TSPs exist," he said. "Giving our partners the choice to seamlessly integrate any solution they prefer with the ConnectWise platform allows them to take advantage of the single pane of glass simplicity in a way that makes sense for their unique needs."

Craig Fulton, Chief Product Officer for ConnectWise, also took the stage during today's keynote to reveal several new enhancements and features of the ConnectWise suite.

ConnectWise Automate(TM) starts its transition to a web implementation, allowing for tighter integration between Automate and ConnectWise Manage(TM). The first two functions moving to the web are computer management and a new network map feature, both of which can be accessed from any device with a browser and without having to leave the service ticket.  These enhancements are expected to be available in the first quarter of 2018.

ConnectWise Perspective, an innovative addition to remote control functionality, will enable a smartphone video connection between a TSP's customer and a technician, and will relay a live video feed from that customer's smartphone to the technician. Available in the second quarter of 2018, Perspective will enhance service delivery by auto scanning barcodes, recording session time, adding workstation information into tickets and more.

"One of the many benefits of Perspective is what it means for our partners when it comes to training and staffing. Junior technicians can operate in the field with a senior technician's support back in the office," said Fulton. "Additionally, Perspective enables a customer to play the role of field technician, in conjunction with the communication back to a technician in the office."

IT Nation is the largest annual event in the technology solutions provider industry. The three-day conference in Orlando brings together representatives that sell, service and support technology from across the globe. This year's IT Nation runs through November 10.

Follow ConnectWise  
LinkedIn 
ConnectWise Blog  
Twitter  
Facebook 
YouTube 

About ConnectWise 
ConnectWise transforms how technology solution providers successfully build, manage, and grow their businesses. Our award-winning set of software solutions provide a fully integrated, seamless experience to companies in more than 50 countries, giving them the ability to increase their productivity, efficiency, and profitability. When combined with our relentless commitment to innovation, powerful network of ideas and experts, unparalleled passion for our users, and more than 35 years of experience, ConnectWise software solutions deliver the support companies want at each step of their business journey. For more information, visit www.ConnectWise.com.

Copyright © 2017 ConnectWise. All Rights Reserved. All trademarks, trade names, service marks and logos referenced herein belong to their respective companies. All other company, product, or service names may be trademarks or service marks of others and are the property of their respective owners. 

Media Contacts: 
Elizabeth Bassler
EBassler@ConnectWise.com
813.300.1292

Diane Rose for ConnectWise
diane@dkrcomms.com
727.238.7567




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ConnectWise via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum